Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

320

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

November 30, 2025

Conditions

AnemiaNeoplasmsChemotherapeutic-Induced Anemia

Interventions

BIOLOGICAL

Erythropoietin

Administration of Erythropoietin 150UI/Kg/week divided into 3 doses, IV, for a period of 12 weeks, in patients with hemoglobin between \<12g/dL